# OnCo record mt-303 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mt-303/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mt-303" ;
  schema:name "MT-303"@en ;
  schema:description "MT-303 is an experimental in vivo CAR therapy from CREATE Medicines, in phase 1 trials for liver cancer (hepatocellular carcinoma)."@en ;
  schema:url <https://onco.cc/drugs/mt-303/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://createmedicines.com/>, <https://www.biospace.com/press-releases/create-medicines-doses-first-patient-in-frontline-hcc-trial-evaluating-mt-303-an-in-vivo-car-therapy-in-combination-with-standard-of-care-immunotherapy>, <https://clinicaltrials.gov/study/NCT06478693> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "In vivo CAR therapy: mRNA in lipid nanoparticles that programmes myeloid cells" ;
  onco:cancers <https://onco.cc/cancers/hcc/> ;
  onco:targets <https://onco.cc/targets/gpc3/> ;
  onco:companies <https://onco.cc/companies/create-medicines/> ;
  onco:trials <https://onco.cc/trials/nct06478693/> .